Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) Income from Continuing Operations (2016 - 2025)

Wave Life Sciences (WVE) has disclosed Income from Continuing Operations for 11 consecutive years, with 53179000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Income from Continuing Operations fell 281.79% year-over-year to 53179000.0, compared with a TTM value of 204378000.0 through Dec 2025, down 110.68%, and an annual FY2025 reading of 204378000.0, down 110.68% over the prior year.
  • Income from Continuing Operations was 53179000.0 for Q4 2025 at Wave Life Sciences, up from 53852000.0 in the prior quarter.
  • Across five years, Income from Continuing Operations topped out at 29253000.0 in Q4 2024 and bottomed at 61780000.0 in Q3 2024.
  • Average Income from Continuing Operations over 5 years is 32149500.0, with a median of 38290000.0 recorded in 2021.
  • Peak annual rise in Income from Continuing Operations hit 279.7% in 2024, while the deepest fall reached 951.9% in 2024.
  • Year by year, Income from Continuing Operations stood at 34785000.0 in 2021, then decreased by 25.65% to 43709000.0 in 2022, then surged by 62.76% to 16279000.0 in 2023, then skyrocketed by 279.7% to 29253000.0 in 2024, then plummeted by 281.79% to 53179000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for WVE at 53179000.0 in Q4 2025, 53852000.0 in Q3 2025, and 50469000.0 in Q2 2025.